New Advances and Opportunities for Improvement in HR+/HER2- Early Breast Cancer

New Advances and Opportunities for Improvement in HR+/HER2- Early Breast Cancer

2023 Updates In Metastatic Breast Cancer TreatmentПодробнее

2023 Updates In Metastatic Breast Cancer Treatment

Navigating the Expanding Treatment Arsenal for ER+/HER2- Breast CancerПодробнее

Navigating the Expanding Treatment Arsenal for ER+/HER2- Breast Cancer

ClarifyingComplexities of ExpandingTreatmentOptionsFor AdvancedAndEarly-Stage HR+/HER2- BreastCancerПодробнее

ClarifyingComplexities of ExpandingTreatmentOptionsFor AdvancedAndEarly-Stage HR+/HER2- BreastCancer

Lightning Updates | 2023 Best of Breast ConferenceПодробнее

Lightning Updates | 2023 Best of Breast Conference

What's New and on the Horizon for Metastatic Breast Cancer?Подробнее

What's New and on the Horizon for Metastatic Breast Cancer?

A Clinician's Perspective on Cancer Drug DevelopmentПодробнее

A Clinician's Perspective on Cancer Drug Development

Advanced Breast Cancer: Challenges in Pathways DevelopmentПодробнее

Advanced Breast Cancer: Challenges in Pathways Development

Optimizing Therapy in HER2+ Disease with Dr. Reshma MahtaniПодробнее

Optimizing Therapy in HER2+ Disease with Dr. Reshma Mahtani

HER2 In Breast Cancer: Testing Guidelines and New Treatment ApproachesПодробнее

HER2 In Breast Cancer: Testing Guidelines and New Treatment Approaches